Unicharm (OTCMKTS:UNICY - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 27,100 shares, a growth of 86.9% from the August 31st total of 14,500 shares. Based on an average trading volume of 1,151,200 shares, the days-to-cover ratio is presently 0.0 days. Based on an average trading volume of 1,151,200 shares, the days-to-cover ratio is presently 0.0 days.
Unicharm Stock Up 4.6%
Unicharm stock opened at $3.37 on Friday. Unicharm has a twelve month low of $3.06 and a twelve month high of $8.10. The firm has a market cap of $11.80 billion, a PE ratio of 16.84 and a beta of 0.24. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.87 and a current ratio of 2.32. The firm's 50 day moving average price is $3.33 and its two-hundred day moving average price is $3.77.
Unicharm (OTCMKTS:UNICY - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.03 earnings per share for the quarter. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.81 billion. On average, research analysts predict that Unicharm will post 0.17 EPS for the current fiscal year.
About Unicharm
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.